Literature DB >> 31871078

Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model.

Vincent H Tam1, Daniel N Cohen2,3, Kimberly R Ledesma4, Bobby Guillory3, Katrina Chan4, Kevin W Garey4.   

Abstract

Subcutaneous administration is a novel way to deliver antibiotics for an infection, but intolerability has been reported. Evaluating the local tolerability of subcutaneously administered antibiotics is not standardized. The goal of this study was to develop an animal model to assess the subcutaneous administration of ceftriaxone. Sprague-Dawley rats were given daily subcutaneous injections for 12 days. The back of each animal was divided into 4 quadrants, with injections rotating each day among the quadrants. Ceftriaxone (1,000 mg/kg of body weight daily) was given in different concentrations and durations. Normal saline and potassium chloride solutions (2 meq/2 ml) were used as negative and positive controls, respectively. After the treatment course, skin samples were biopsied, and the local inflammatory response was assessed histologically using a semiquantitative scoring system. The histopathology scores were compared using a Kruskal-Wallis test. Injections with potassium chloride resulted in full-thickness skin necrosis with subcutaneous atrophy that was not seen in the saline-injected animals; inflammation of the muscular panniculus was observed, with various degrees of myocyte injury. Serosanguinous cavity formation in the subcutaneous compartment was observed when ceftriaxone (125 mg/ml) was given as a bolus injection, but the extent of the local tissue response was remarkably reduced when the same ceftriaxone dose was given at a lower concentration (25 mg/ml) over 120 min (P = 0.63, compared to saline controls). At a low concentration, ceftriaxone infusion was found to be well tolerated in this animal tissue necrosis model. If validated, the model could be an instrumental platform to evaluate different pharmaceutical formulations for subcutaneous delivery.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  inflammation; injury assessment; necrosis

Year:  2020        PMID: 31871078      PMCID: PMC7038272          DOI: 10.1128/AAC.02090-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Development and validation of a histological index for UC.

Authors:  Mahmoud H Mosli; Brian G Feagan; Guangyong Zou; William J Sandborn; Geert D'Haens; Reena Khanna; Lisa M Shackelton; Christopher W Walker; Sigrid Nelson; Margaret K Vandervoort; Valerie Frisbie; Mark A Samaan; Vipul Jairath; David K Driman; Karel Geboes; Mark A Valasek; Rish K Pai; Gregory Y Lauwers; Robert Riddell; Larry W Stitt; Barrett G Levesque
Journal:  Gut       Date:  2015-10-16       Impact factor: 23.059

2.  Subcutaneous administration of cefepime.

Authors:  Paul Walker; Melinda N Neuhauser; Vincent H Tam; Jie S Willey; J Lynn Palmer; Eduardo Bruera; Randall A Prince
Journal:  J Pain Symptom Manage       Date:  2005-08       Impact factor: 3.612

3.  Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients.

Authors:  Cécile Pouderoux; Agathe Becker; Sylvain Goutelle; Sébastien Lustig; Claire Triffault-Fillit; Fatiha Daoud; Michel Henry Fessy; Sabine Cohen; Frédéric Laurent; Christian Chidiac; Florent Valour; Tristan Ferry
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

4.  Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks.

Authors:  E Forestier; M Paccalin; C Roubaud-Baudron; T Fraisse; G Gavazzi; J Gaillat
Journal:  Clin Microbiol Infect       Date:  2014-11-23       Impact factor: 8.067

5.  Tolerance of subcutaneously administered antibiotics: a French national prospective study.

Authors:  Claire Roubaud-Baudron; Emmanuel Forestier; Thibaut Fraisse; Jacques Gaillat; Benoit de Wazières; Leonardo Pagani; Isabelle Ingrand; Louis Bernard; Gaëtan Gavazzi; Marc Paccalin
Journal:  Age Ageing       Date:  2017-01-08       Impact factor: 10.668

6.  Subcutaneous and intravenous ceftriaxone administration in patients more than 75 years of age.

Authors:  D Gauthier; S Schambach; J Crouzet; S Sirvain; T Fraisse
Journal:  Med Mal Infect       Date:  2014-06-02       Impact factor: 2.152

Review 7.  Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries.

Authors:  Roman Mathaes; Atanas Koulov; Susanne Joerg; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2016-07-01       Impact factor: 3.534

8.  Antibiotics by Subcutaneous Route: A Safe and Efficient Alternative.

Authors:  Oscar Duems Noriega; Sulema N Yarlequé León
Journal:  J Am Med Dir Assoc       Date:  2018-04-27       Impact factor: 4.669

9.  Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.

Authors:  Richard G Langley; Charles N Ellis
Journal:  J Am Acad Dermatol       Date:  2004-10       Impact factor: 11.527

10.  Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance.

Authors:  Cecile Berteau; Orchidée Filipe-Santos; Tao Wang; Humberto E Rojas; Corinne Granger; Florence Schwarzenbach
Journal:  Med Devices (Auckl)       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.